Risk assessment in haematopoietic stem cell transplantation

References 

1. Copelan EA. Hematopoietic stem cell transplantation. The New England Journal of Medicine. 2006;354:1813–1826
   • CrossRef
2. Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic myeloid leukemia. Recommendations from an expert panel on behalf of the European Leukemia Net. Blood. 2006;108:1809–1820
   • MEDLINE
   • CrossRef
3. Passweg J, Baldomero H, Chapuis B, et al. Swiss Transplant Working Group Blood and Marrow Transplantation Board Haematopoietic stem cell transplantation in Switzerland. Report from the Swiss Transplant Working Group Blood and Marrow Transplantation (STABMT) Registry 1997–2003. Swiss Medical Weekly. 2006;136:50–58
4. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation. Lancet. 1988;18:1379–1382
5. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 1998;352:1087–1092
   • Abstract
   • Full Text
   • Full-Text PDF (85 KB)
   • CrossRef
6. Gratwohl A, Brand R, Apperley J, et al. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2006;91:513–521
7. Parimon T, Au DH, Martin PJ, et al. A risk score for mortality after allogeneic hematopoietic cell transplantation. Annals of Internal Medicine. 2006;144:407–414
8. Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood. 2003;102:1131–1137
   • MEDLINE
   • CrossRef
9. Gratwohl A, Baldomero H, Schwendener A et al. for the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT) (JACIE). Haematopoietic stem cell transplants for chronic myeloid leukaemia in Europe. Impact of cost considerations. Leukemia 2006, in press.